On 18 June 2025, Yichang Hec Changjiang Pharmaceutical Co. Ltd. announced a disclosure of internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Financial Trading Limited engaged in a derivative contract involving 685,600 reference securities, with a maturity date set for 17 June 2026. CICC Financial Trading Limited, an exempt principal trader connected with the Offeror and owned by China International Capital Corporation Limited, conducted these dealings for its own account.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.